$AMBA

Chen Yun-Lung sold $469K of AMBA

Chen Yun-Lung (VP, Business Dev. & Marketing) sold 5,958 shares of AMBARELLA INC (AMBA) at $78.66 ($0.47M total) on 2026-07-09.

Original reporting
SEC EDGAR · Chen Yun-Lung
Published Jul 10, 2026, 8:55 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 10, 2026, 9:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMBA
Neutral
medium confidence
Mentioned
$AMBA
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBANeutralLow
01

Why it matters

Traders may monitor insider activity as a sentiment input, but this specific disclosure lacks fundamental catalysts (no earnings, guidance, deal, or regulatory action).

02

Market read

A disclosed insider open-market sale totaling about $469K, with no 10b5-1 plan stated, is more of a sentiment datapoint than a tradable fundamental catalyst.

03

What to watch

No context is provided on total insider holdings, prior sale cadence, or whether other insiders executed offsetting buys, limiting inference.

Relevance 4/10Novelty 3/10Timing: Filed 2026-07-10, disclosing a 2026-07-09 insider sale.

Background

The article is an SEC Form 4 insider transaction disclosure for AMBARELLA Inc, reported by VP Chen Yun-Lung.

Company-level read

Ticker impact

$AMBANeutralMedium confidence
Context

AMBARELLA insider Chen Yun-Lung sold 5,958 shares on 2026-07-09 at $78.6600, totaling $468,656.28.

Expected impact

Likely limited, short-lived sentiment impact; no clear directional signal for fundamentals from this single sale.

Evidence & confidence

The filing is a primary Form 4 disclosure, but the article provides only a sale size and price, with no accompanying guidance, contract, or operational update.

Market effects

Minimal; insider selling in a single semiconductor/EDA-adjacent name does not establish a sector-wide signal from this text alone.

None indicated.

None indicated.

Counterpoint

The sale may be for diversification or personal liquidity needs, and the absence of a stated 10b5-1 plan does not necessarily imply negative expectations.

Key entities

  • AMBARELLA INC

    Subject of the Form 4 insider sale by VP Chen Yun-Lung.

  • Chen Yun-Lung

    VP, Business Dev. & Marketing; sold 5,958 shares on 2026-07-09.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMBAMedAI 8/10

Ambarella Q2 Earnings Call Highlights

Ambarella (AMBA) announced a $50M stock buyback program. Q3 revenue forecasted at $115M-$124M, with IoT demand driving growth. Memory constraints may impact customers. Raised 5-year market forecast to $22.9B. Partnered with Capgemini and Macnica for indirect sales. X7 AI accelerator sampling for edge infrastructure.

$AMBAHigh

AMBARELLA INC (AMBA): Results of Operations and Financial Condition

AMBARELLA INC (AMBA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ambarella, Inc. Announces Second Quarter Fiscal Year 2027 Financial Results September 3, 2026 —Santa Clara, Calif. – Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced second quarter fiscal 2027 financial results for the period ended Ju

$AMBAMedAI 8/10

Usain Bolt Just Got an AI Rival – Meet the Stocks Behind It

Unitree Robotics, a Chinese company, unveiled a humanoid robot 'Superman' claiming it runs faster than Usain Bolt. The company's IPO on the Shanghai Stock Exchange saw shares surge 460%, valuing it at $50 billion. Investors are betting on the humanoid robotics sector and its supply chain, including companies like Ambarella, Ouster, Cognex, Regal Rexnord, and Harmonic Drive Systems, which saw gains in July.